Invention Grant
- Patent Title: N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulators
-
Application No.: US15699112Application Date: 2017-09-08
-
Publication No.: US10251893B2Publication Date: 2019-04-09
- Inventor: Dai Cheng , Wenqi Gao , Dong Han , Shifeng Pan , Guobao Zhang
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61P35/02 ; A61K31/444 ; A61K31/496 ; A61K31/497 ; A61K31/501 ; A61K31/506 ; A61K31/541 ; C07D403/14 ; C07D213/75 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D413/14 ; C07D417/12 ; C07D417/14 ; A61K31/4439
Abstract:
The present invention relates to methods for modulating the Wnt signaling pathway using compounds of Formula (1), wherein A1, Y and Z all represent rings.
Public/Granted literature
- US20180000832A1 N-(HETERO)ARYL, 2-(HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS WNT SIGNALING MODULATORS Public/Granted day:2018-01-04
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
